{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:10:37Z","timestamp":1783649437064,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKJYD2021054"],"award-info":[{"award-number":["SKJYD2021054"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["24KJB350007"],"award-info":[{"award-number":["24KJB350007"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jinorgbio.2026.113214","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:46:49Z","timestamp":1767455209000},"page":"113214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Copper-polypyridine complexes as potent SARS-CoV-2 3CLpro inhibitors: Synthesis, evaluation, and molecular basis based on computational study"],"prefix":"10.1016","volume":"277","author":[{"given":"Xiaolin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2026.113214_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40001-021-00626-3","article-title":"Potential therapeutic options for COVID-19: an update on current evidence","volume":"27","author":"Niknam","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun. Biol."},{"issue":"15","key":"10.1016\/j.jinorgbio.2026.113214_bb0015","article-title":"Treatment for COVID-19: an overview","volume":"889","author":"Stasi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"738","key":"10.1016\/j.jinorgbio.2026.113214_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0979","article-title":"An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutation","volume":"16","author":"Westberg","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-022-00852-9","article-title":"A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies","volume":"29","author":"Kumari","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41579-024-01036-y","article-title":"COVID-19 drug discovery and treatment option","volume":"22","author":"Chan","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0035","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41467-021-22362-2","article-title":"Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors","volume":"12","author":"Iketani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s42269-021-00487-0","article-title":"A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19)","volume":"45","author":"Fouad","year":"2021","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111567","article-title":"Discovery of \u03b2-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models","volume":"181","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/bca\/5551967","article-title":"Combining experimental and computational tools to unravel copper-based metallodrug interactions with proteins","volume":"2025","author":"Pe\u00f1a","year":"2025","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0055","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ejmech.2017.10.058","article-title":"Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor","volume":"143","author":"Qin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jinorgbio.2018.11.019","article-title":"In-vitro evaluation studies of 7-chloro-4-aminoquinoline Schiff bases and their copper complexes as cholinesterase inhibitors","volume":"191","author":"Zanon","year":"2019","journal-title":"J. Inorg. Biochem."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113214_bb0065","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/acsmedchemlett.9b00284","article-title":"Novel copper complexes that inhibit the proteasome and trigger apoptosis in triple-negative breast cancer cells","volume":"10","author":"Li","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/bca\/4226220","article-title":"Semax, a copper chelator peptide, decreases the Cu(II)-catalyzed ROS production and cytotoxicity of a\u03b2 by metal ion stripping and redox silencing","volume":"2025","author":"Tomasello","year":"2025","journal-title":"Bioinorg. Chem. Appl."},{"issue":"42","key":"10.1016\/j.jinorgbio.2026.113214_bb0075","doi-asserted-by":"crossref","first-page":"14098","DOI":"10.1039\/D1SC03526F","article-title":"Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate","volume":"12","author":"Tao","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0080","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41564-020-00802-x","article-title":"Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters","volume":"5","author":"Yuan","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"31","key":"10.1016\/j.jinorgbio.2026.113214_bb0085","doi-asserted-by":"crossref","first-page":"16740","DOI":"10.1002\/anie.202107715","article-title":"ReI tricarbonyl complexes as coordinate covalent inhibitors for the SARS-CoV-2 main cysteine protease","volume":"60","author":"Karges","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113214_bb0090","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/v13060980","article-title":"Noble metal organometallic complexes display antiviral activity against SARS-CoV-2","volume":"13","author":"Chuong","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0095","article-title":"The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2","volume":"1246","author":"Arslana","year":"2021","journal-title":"J. Mol. Struc."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113214_bb0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1039\/D2SC05473F","article-title":"Enantioselective inhibition of the SARS-CoV-2 main protease with rhenium(I) picolinic acid complexes","volume":"14","author":"Karges","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112403","article-title":"Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis","volume":"250","author":"Wang","year":"2024","journal-title":"J. Inorg. Biochem."},{"issue":"30","key":"10.1016\/j.jinorgbio.2026.113214_bb0110","doi-asserted-by":"crossref","first-page":"16973","DOI":"10.1039\/C8RA00954F","article-title":"Copper complexes as prospective anticancer agents: in vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest","volume":"8","author":"Mahendiran","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.carbpol.2017.09.095","article-title":"Fabrication and characterization of copper (II)-chitosan complexes as antibiotic-free antibacterial biomaterial","volume":"179","author":"Gritsch","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110349","article-title":"Multi-target activity of copper complexes; antibacterial, DNA binding, and molecular docking with SARS-CoV-2 receptor","volume":"373","author":"Arthi","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0125","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10534-021-00339-4","article-title":"Antiviral properties of copper and its alloys to inactivate covid-19 virus: a review","volume":"34","author":"Govind","year":"2021","journal-title":"Biometals"},{"issue":"10","key":"10.1016\/j.jinorgbio.2026.113214_bb0130","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1039\/C5NJ01059D","article-title":"Structural modeling, in vitro antiproliferative activity, and the effect of substituents on the DNA fastening and scission actions of heteroleptic copper(ii) complexes with terpyridines and naproxen","volume":"39","author":"Mahendiran","year":"2015","journal-title":"New J. Chem."},{"issue":"18","key":"10.1016\/j.jinorgbio.2026.113214_bb0135","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1039\/C5DT03831F","article-title":"Targeting of DNA molecules, BSA\/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes","volume":"45","author":"Mahendiran","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-9752-7_9","volume":"2053","author":"Bitencourt-Ferreira","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113214_bb0145","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113214_bb0150","author":"Lu"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113214_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:32:06Z","timestamp":1782117126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013426000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S0162013426000036"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113214","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copper-polypyridine complexes as potent SARS-CoV-2 3CLpro inhibitors: Synthesis, evaluation, and molecular basis based on computational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113214"}}